Edward Walker , the lead scientist and researcher behind Amarasate , setting the stage for what he describes as a very different supplement story than the podcast typically covers
The short, practical answer is: sometimes, for modest goals - but not always for large, medically supervised weight loss
Together, slower digestion and a stronger fullness signal sharply reduce the drive to eat, and the weight comes off commonly around 15 percent of body weight with semaglutide and up to roughly 20 percent with tirzepatide in head-to-head clinical trials, though real-world results are often more modest
The situation may now begin to change, at least in the case of Semaglutide
Scenario B Tirzepatide 15 mg/week plateau at 10% total weight loss, side effects mild